Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 4Completed 4Withdrawn 1Unknown 1Terminated 1Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Seizures 1Central Nervous System Neoplasms 1Brain Neoplasms 1

Interventions

Temozolomide 19Magnetic Resonance Spectroscopy 16Radiosurgery 12Bevacizumab 12Radiotherapy 10Radiation 8pembrolizumab 6Specimen Handling 6Methotrexate 6Surgical Procedures, Operative 5Topotecan 4TIC10 compound 4Isotretinoin 4Carmustine 4Carboplatin 4abemaciclib 3Trastuzumab 3Thiotepa 3Standard of Care 3Nivolumab 3Magnetic Resonance Imaging 3Lomustine 3Irinotecan 3Erlotinib Hydrochloride 3Drug Therapy 3Dexamethasone 3vandetanib 2thymoglobulin 2temsirolimus 2pazopanib 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Withdrawn × Levetiracetam × CNS × Clear all
NCT00415376 2012-05-18

Levetiracetam in Treating Patients With Seizures Caused by Brain Metastases

Northwestern University

Phase NA Withdrawn
CNS

Brain Neoplasms, Seizures, Central Nervous System Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡